Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Rubius Therapeutics, Inc. | ruby-20201231xex32d2.htm |
| EX-32.1 - EX-32.1 - Rubius Therapeutics, Inc. | ruby-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Rubius Therapeutics, Inc. | ruby-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Rubius Therapeutics, Inc. | ruby-20201231xex31d1.htm |
| EX-21.1 - EX-21.1 - Rubius Therapeutics, Inc. | ruby-20201231xex21d1.htm |
| 10-K - 10-K - Rubius Therapeutics, Inc. | ruby-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-237103, 333-231478 and 333-226226) and Form S-3 (No. 333-232955) of Rubius Therapeutics, Inc. of our report dated February 23, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 23, 2021